Why Am I Seeing This? We Have an Answer for You

News Feed is always personalized to you — and starting today you’ll have even more information and control over your experience.

Curve, the ‘over-the-top’ banking platform, raises $55M at a $250M valuation

Curve, the London-based “over-the-top banking platform,” has raised $55 million in new funding. The startup lets you consolidate all of your bank cards into a single Curve card and app to make it easier to manage your spending and access other benefits. Read more: https://tcrn.ch/2LTLbyx

Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist

OSAKA, Japan, /PRNewswire/ — Shionogi & Co., Ltd. (hereafter “Shionogi” or “the Company”) announces that the Company has concluded an agreement with Eddingpharm (hereafter “Eddingpharm”) to license-out lusutrombopag, a thrombopoietin receptor agonist (brand name in Japan: MULPLETA®). Read more: https://prn.to/2XONsh1

Live Long And Prosper: How Anne Wojcicki’s 23andMe Will Mine Its Giant DNA Database For Health And Wealth

Anne Wojcicki is 45 minutes late, something so encoded in her habits as 23andMe’s CEO that employees have stopped complaining about it. They know it’s hardwired. Read more: http://bit.ly/2Y3y6sW

尹思哲

✎ Just do it ✎

Recently curate: 尹思哲

Curve, the ‘over-the-top’ banking platform, raises $55M at a $250M valuation

Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist

Live Long And Prosper: How Anne Wojcicki’s 23andMe Will Mine Its Giant DNA Database For Health And Wealth

You may also like

現在過去

關於這裡

那些日子

尹思哲

✎ Just do it ✎